All News #Library
Biotech
Nicox’s NCX 470 Shows 12-Month Efficacy in Denali Trial
02 Oct 2025 //
GLOBENEWSWIRE
Kowa initiates NCX 470 Phase 3 trial for Nicox in Japan
05 Aug 2025 //
GLOBENEWSWIRE
Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO
27 Feb 2024 //
GLOBENEWSWIRE
Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data
03 Jul 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support